ARCHIVES

FDA Continues Bureaucratic Delays Of Cancer INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

NCI To Stop All Support For WHT After March 31

February 5, 1988

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

In Brief: Basic Research Chief At Frederick Will Be A Nominal Litton Employee To Avoid NCI Staff, Salary Ceilings

March 1, 1974

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997